Cogitat

Private

RoystonHealthcare & Life Scienceshttps://cogitat.io/

Last Round

Accelerator

Sep 3, 2025

Total Funding Raised

$2.28M

Company Overview

Cogitat is a neurotechnology company that develops device-agnostic AI software to convert brain waves into digital commands for brain-computer interface applications.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Defense Tech, Health IoT

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

brain-computer interfaceBCIEEG decodingneurotechnologymind controlneurorehabilitationtelerehabilitationattention monitoringcognitive performancewearable neurotechnon-invasive BCIbrainwave controlmedical AIthought-to-textneural interface

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cogitat Comparables

Compare Cogitat with similar companies based on industry and business-model similarity.

Cogitat comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Cogitat Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Accelerator	Sep 3, 2025
Accelerator	Jul 7, 2025
Accelerator	Jan 10, 2025
Accelerator	Dec 11, 2024
Accelerator	Jul 1, 2024
Grant	Jun 19, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Dimitrios Adamos

Co-Founder and Chief Technology Officer

Founding Team

Allan Ponniah

Chief Executive Officer

Executive Team

Cogitat Investors

Notable investors and investment history

Cogitat investors
Investor	Rounds
Innovate UK	Accelerator, Grant
Cambridge Angels	Pre Seed
DIANA	Accelerator
Pioneer Group	Accelerator
Creative Destruction Lab	Accelerator
Innovate UK	Accelerator, Grant
Metavallon	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 6, 2026
Monthly visitors grew 38% MoM, from 619 to 856.
Dec 11, 2024
$105K raised from DIANA

View all signals

Cogitat Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cogitat Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cogitat's valuation, stock price, and market status.

Firmographic Details

HeadquartersRoyston

Employee Range14

Year Founded2020

Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.